Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ChargePoint Holdings, Inc. (SBE)
|
Add to portfolio |
|
|
|
| Price: |
$19.52
| | Metrics |
| OS: |
353.3
|
M
| |
-102
|
% ROE
|
| Market cap: |
$6.9
|
B
| |
-170
|
% ROIC
|
|
Net debt:
|
$11.9
|
M
| |
|
|
|
EV:
|
$6.91
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($306)
|
M
| |
|
|
|
EBIT
|
($332)
|
M
| |
|
|
| EPS |
($0.98)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Dec-31-20 | Jan-31-20 | Jan-31-19 |
| Revenues | 468.1 | 241.0 | 146.5 | -0.2 | 144.5 | 92.0 |
| Revenue growth | 94.2% | 64.5% | 1.4% | | 57.0% | |
| Cost of goods sold | 382.2 | 187.5 | 113.5 | 0.0 | 126.5 | 72.5 |
| Gross profit | 85.9 | 53.5 | 32.9 | -0.2 | 18.0 | 19.5 |
| Gross margin | 18.4% | 22.2% | 22.5% | 100.0% | 12.5% | 21.2% |
| Sales and marketing | 142.4 | 92.6 | 53.0 | | 57.0 | 56.4 |
| Research and development | 195.0 | 145.0 | 75.0 | | 69.5 | 50.5 |
| General and administrative | 90.4 | 81.4 | 25.9 | 5.7 | 23.9 | 17.9 |
| EBITA | -330.1 | -260.8 | -121.0 | -5.9 | -132.4 | -105.1 |
| EBITA margin | -70.5% | -108.2% | -82.6% | 2974.6% | -91.6% | -114.2% |
| Amortization of intangibles | 11.6 | 4.6 | | | | 0.2 |
| EBIT | -341.8 | -265.4 | -121.0 | -5.9 | -132.4 | -105.3 |
| EBIT margin | -73.0% | -110.1% | -82.6% | 2974.6% | -91.6% | -114.4% |
| Pre-tax income | -347.3 | -135.2 | -196.8 | -4.8 | -134.1 | -108.0 |
| Income taxes | -2.2 | -2.9 | 0.2 | 0.2 | 0.2 | 0.1 |
| Tax rate | 0.6% | 2.2% | | | | |
| Net income | -345.1 | -451.7 | -274.2 | -5.0 | -134.3 | -108.1 |
| Net margin | -73.7% | -187.4% | -187.2% | 2495.4% | -93.0% | -117.4% |
| |
| Diluted EPS | ($1.02) | ($1.49) | ($18.14) | ($0.13) | ($15.10) | ($24.89) |
| Shares outstanding (diluted) | 338.5 | 302.5 | 15.1 | 39.3 | 8.9 | 4.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|